The overall goal of this project is to understand the mechanisms of peptide hormone-receptor interaction and subsequent signal transduction at the molecular (protein) level. In addition to the insulin receptor that we have been purifying, we have established purification of the insulin-like growth factor (IGF)-I will be studied as model systems in this proposal. The two receptors share similar but complex structure. The subunit structure is disulfide-linked in a beta-alpha-alpha-beta form. Ligand-binding and tyrosine-specific protein kinase (TPK) activities are separately carried by the alpa and beta subunits, respectively. Upon ligand binding, this kinase is activated, which is now thought to be a prerequisite for signal transduction. This proposal covers the following specific aims: 1) Characterization of insulin and IGF-I receptor tyrosine protein kinases: Insulin and IGF-I receptors are generally believed to mediate metabolic and growth effects, respectively. Although 84% identical at the primakry structure level, their kinases should be qualitatively different if the two receptors have different roles and signal pathways. We will screen substrates, inhibitors and activators that are specific for each kinase. We will then use them for biochemical characterization of the kinases to understand differences in their signal transduction pathways. 2) Substructural domain analysis of the insulin receptor by limited proteolysis and protein microanalyses: Although x-ray chrystallography analysis has to be made to further reveal the exact structure of the insulin receptor, protein chemical studies such as domain sanalysis are essential to fill the gap existing between primary and three-dimensional structures. 3) Structural-functional relationships of the IGF-I receptor in comparison with the well-studied insulin receptor: Studies on the IGF-1 receptor have become more feasible since IGF-I and 125I-labeled IGF-I are now commercially available. In addition to the purified placental receptor, we will construct vectors using the IGF-I cDNA and express the intact receptor and the kinase domain in mammalian or insect expression systems. This will allow us to further characterize binding and kinase activities of the IGF-I receptor. The comparison of similarities and differences of the """"""""isoreceptors"""""""" in the proposed studies should lead to better understanding of IGF-I receptor function at the molecular level. These studies should also allow us to project three-dimensional organization of the two receptors from one- dimensional (primary structural) information.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK034427-04A2
Application #
3232769
Study Section
Endocrinology Study Section (END)
Project Start
1984-07-01
Project End
1993-11-30
Budget Start
1988-12-01
Budget End
1989-11-30
Support Year
4
Fiscal Year
1989
Total Cost
Indirect Cost
Name
City of Hope/Beckman Research Institute
Department
Type
DUNS #
City
Duarte
State
CA
Country
United States
Zip Code
91010
Li, S; Termini, J; Hayward, A et al. (1998) The carboxyl-terminal domain of insulin-like growth factor-I receptor interacts with the insulin receptor and activates its protein tyrosine kinase. FEBS Lett 421:45-9
Kimura, G; Kasuya, J; Giannini, S et al. (1996) Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells. Int J Urol 3:39-46
Hashimoto, R; Fujiwara, H; Higashihashi, N et al. (1995) N-terminal deletion mutants of insulin-like growth factor-II (IGF-II) show Thr7 and Leu8 important for binding to insulin and IGF-I receptors and Leu8 critical for all IGF-II functions. J Biol Chem 270:18013-8
Giannini, S; Mohan, S; Kasuya, J et al. (1994) Characterization of insulin-like growth factor-binding proteins produced by cultured fibroblasts from patients with noninsulin-dependent diabetes mellitus, insulin-dependent diabetes mellitus, or obesity. J Clin Endocrinol Metab 79:1824-30
Kasuya, J; Li, S L; Orr, S et al. (1994) The purified COOH-terminal domain of the insulin receptor carries activity to stimulate protein kinase activity or autophosphorylation of the beta subunit domain of insulin receptor. Biochem Biophys Res Commun 200:777-83
Kasuya, J; Paz, I B; Maddux, B A et al. (1993) Characterization of human placental insulin-like growth factor-I/insulin hybrid receptors by protein microsequencing and purification. Biochemistry 32:13531-6
Yan, P F; Li, S L; Liang, S J et al. (1993) The role of COOH-terminal and acidic domains in the activity and stability of human insulin receptor protein tyrosine kinase studied by purified deletion mutants of the beta subunit domain. J Biol Chem 268:22444-9
Li, S L; Kato, J; Paz, I B et al. (1993) Two new monoclonal antibodies against the alpha subunit of the human insulin-like growth factor-I receptor. Biochem Biophys Res Commun 196:92-8
Xiong, L; Kasuya, J; Li, S L et al. (1992) Growth-stimulatory monoclonal antibodies against human insulin-like growth factor I receptor. Proc Natl Acad Sci U S A 89:5356-60
Li, S L; Yan, P F; Paz, I B et al. (1992) Human insulin receptor beta-subunit transmembrane/cytoplasmic domain expressed in a baculovirus expression system: purification, characterization, and polylysine effects on the protein tyrosine kinase activity. Biochemistry 31:12455-62

Showing the most recent 10 out of 21 publications